Rock Springs Capital Management LP Tg Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $8.66 Million - $13 Million	-266,520 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $9.26 Million - $12.1 Million	-222,480 Reduced 45.5%	266,520 $12.8 Million
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $4.9 Million - $10.6 Million	-193,926 Reduced 28.4%	489,000 $25.4 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $6.08 Million - $14.9 Million	682,926 New	682,926 $13.3 Million

338

87.7M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.68B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.